Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

February 01, 2020; Volume 97,Issue 2

Special Section on New Opportunities in Targeting WNT Signaling

  • You have access
    Molecular Pharmacology of Class F Receptor Activation
    Pawel Kozielewicz, Ainoleena Turku and Gunnar Schulte
    Molecular Pharmacology February 2020, 97 (2) 62-71; DOI: https://doi.org/10.1124/mol.119.117986
  • Open Access
    Wnt Signaling and Drug Resistance in Cancer
    Zheng Zhong and David M. Virshup
    Molecular Pharmacology February 2020, 97 (2) 72-89; DOI: https://doi.org/10.1124/mol.119.117978
  • Open Access
    Interventions in WNT Signaling to Induce Cardiomyocyte Proliferation: Crosstalk with Other Pathways
    W. Matthijs Blankesteijn
    Molecular Pharmacology February 2020, 97 (2) 90-101; DOI: https://doi.org/10.1124/mol.119.118018

Articles

  • You have access
    Characterization and Optimization of the Novel Transient Receptor Potential Melastatin 2 Antagonist tatM2NX
    I. Cruz-Torres, D.S. Backos and P.S. Herson
    Molecular Pharmacology February 2020, 97 (2) 102-111; DOI: https://doi.org/10.1124/mol.119.117549
  • You have access
    Alternative Polyadenylation of ABC Transporters of the C-Family (ABCC1, ABCC2, ABCC3) and Implications on Posttranscriptional Micro-RNA Regulation
    Oliver Bruhn, Marie Lindsay, Friederike Wiebel, Meike Kaehler, Inga Nagel, Ruwen Böhm, Christian Röder and Ingolf Cascorbi
    Molecular Pharmacology February 2020, 97 (2) 112-122; DOI: https://doi.org/10.1124/mol.119.116590
  • You have access
    Anaplastic Lymphoma Kinase Regulates Internalization of the Dopamine D2 Receptor
    Donghong He and Amy W. Lasek
    Molecular Pharmacology February 2020, 97 (2) 123-131; DOI: https://doi.org/10.1124/mol.119.117473
  • You have access
    The IKs Ion Channel Activator Mefenamic Acid Requires KCNE1 and Modulates Channel Gating in a Subunit-Dependent Manner
    Yundi Wang, Jodene Eldstrom and David Fedida
    Molecular Pharmacology February 2020, 97 (2) 132-144; DOI: https://doi.org/10.1124/mol.119.117952

Notice of Retraction

  • You have access
    Notice of Retraction: Tripathy S, Chapman JD, Han CY, Hogarth CA, Arnold SLM, Onken J, Kent T, Goodlett DR, and Isoherranen N (2016) All-trans-retinoic acid enhances mitochondrial function in models of human liver. Mol Pharmacol 89(5):560–574; doi:https://doi.org/10.1124/mol.116.103697
    Molecular Pharmacology February 2020, 97 (2) 61; DOI: https://doi.org/10.1124/mol.116.103697retraction
Back to top
PreviousNext

In this issue

Molecular Pharmacology: 97 (2)
Molecular Pharmacology
Vol. 97, Issue 2
1 Feb 2020
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts

Jump to

  • Special Section on New Opportunities in Targeting WNT Signaling
  • Articles
  • Notice of Retraction
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics